Physician profile
Angela Pollard
NPI 1467463190
$8,831.21
in general payments reported to CMS, 2019-2025
35 companies · $756 in 2025
The $756 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,783 · 2020: $561 · 2021: $163 · 2022: $633 · 2023: $1,191 · 2024: $744 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,691.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,000.00 | 2019 | |
| Mayne Pharma Commercial LLC | $952.71 | 2022-2025 | |
| Abbvie INC. | $907.53 | 2019-2023 | |
| Astellas Pharma US INC | $413.58 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $238.57 | 2019-2022 | |
| Exact Sciences Corporation | $221.59 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $212.60 | 2019-2025 | |
| Minerva Surgical, INC | $203.06 | 2023 | |
| Novo Nordisk INC | $175.30 | 2023-2025 | Wegovy, Saxenda |
| Organon LLC | $161.90 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $139.78 | 2022 | |
| Coopersurgical, INC. | $114.77 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $104.53 | 2019-2023 | Balcoltra |
| Vertical Pharmaceuticals, LLC | $95.28 | 2019 | |
| Roche Diagnostics Corporation | $86.38 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $74.35 | 2024 | Zepbound |
| Biogen, INC. | $70.35 | 2024-2025 | Zurzuvae |
| Allergan, INC. | $65.54 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $64.74 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $61.12 | 2019-2023 | |
| Myovant Sciences INC. | $60.78 | 2022 | |
| Ascend Therapeutics US, LLC | $60.28 | 2019-2023 | |
| Ethicon US, LLC | $56.31 | 2023-2025 | Echelon Flex, Dermabond Prineo, Ethicon |
| Lupin INC. | $39.18 | 2019-2020 | |
| Evofem Biosciences, INC. | $37.01 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $35.48 | 2019-2020 | |
| Bausch Health US, LLC | $28.98 | 2023-2024 | Aplenzin |
| Pacira Pharmaceuticals Incorporated | $28.69 | 2023 | Exparel |
| Millicent US INC | $23.56 | 2025 | Femlyv |
| Shield Therapeutics INC | $21.70 | 2023 | Accrufer |
| Medtronic, INC. | $18.24 | 2025 | Rapidvac |
| Exeltis, USA INC. | $16.17 | 2020 | |
| Becton, Dickinson and Company | $15.51 | 2023 | Bd Onclarity |
| Meditrina | $12.89 | 2024 | |
| Amag Pharmaceuticals, INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Pollard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.